Acting Assistant Professor, Center for Epilepsy Drug Discovery (CEDD)
- BS, Pennsylvania State University
- PhD, University of California – Davis
- Drug Resistant Epilepsy
- Preclinical Research
- Medication Adherence
- PHARM 499 – Independent Study
- PHARM 301 – Medications and Health: It’s Not All About the Drugs
Dr. Michelle Guignet is an Acting Assistant Professor in the Center for Epilepsy Drug Discovery (CEDD) at the University of Washington. She earned her PhD in Pharmacology and Toxicology from the University of California – Davis before completing her postdoctoral training under the mentorship of Dr. Steve White at UW. She brings over a decade of experience in preclinical drug discovery from both academic and government spheres. Her expertise lies in developing tools and methodologies that adapt clinical approaches to the preclinical space, effectively bridging the translational gap in drug development to develop therapies for neurological disorders.
In her current position in the Department of Pharmacy, Dr. Guignet actively supports CEDD’s mission to advance promising investigational compounds to clinical studies for the treatment of epilepsy and related conditions. Her work uses innovative platforms for preclinical antiseizure medicine discovery, including novel medication adherence models with profound clinical implications. Her work has been supported by early career awards from the American Epilepsy Society and Institute of Translational Health Sciences and aims to deepen our understanding of clinical and biological factors that lead to drug resistant epilepsy to facilitate the discovery of more effective therapies.